X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Quarterly Results   (SUNP)

Here are the latest quarterly results of Sun Pharma. For more details, see the Sun Pharma financial fact sheet and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Sun Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m79,12771,37062,08866,50366,53269,77172,24269,376 
Other income Rs m1,2222,2451,5202,5481,2923,0281,9983,512 
Turnover Rs m80,34873,61563,60869,05267,82472,79974,23972,888 
Expenses Rs m54,59555,89551,13152,74751,99952,93656,17554,064 
Gross profit Rs m24,53115,8851,45213,75614,53416,83516,0673,168 
Depreciation Rs m3,0683,3823,4663,5873,3934,5524,0164,265 
Interest Rs m1,6654501,0941,5749531,5541,3091,295 
Profit before tax Rs m21,02014,299-1,58911,14411,47913,75612,7391,119 
Tax Rs m3,7294431,6181,1147,487-1,7671,6392,189 
Profit after tax Rs m17,29113,856-3,20710,0303,99215,52311,101-1,070 
Gross profit margin %31.022.32.320.721.824.122.24.6 
Effective tax rate %17.73.1-101.810.065.2-12.812.9195.6 
Net profit margin %21.919.4-5.215.16.022.215.4-1.5 
Diluted EPS Rs 7.2 5.8 -1.3 4.2 1.7 6.4 4.6 -0.4  
Diluted EPS (TTM) Rs 32.0 30.7 20.9 15.8 10.3 10.9 16.9 12.3  
 Subscriber Feature View View View View          
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Sun Pharma 2QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DIVIS LABORATORIES  CADILA HEALTHCARE  WYETH LTD  FULFORD INDIA  BIOCON LTD  

Compare SUN PHARMA With:   DIVIS LABORATORIES  CADILA HEALTHCARE  WYETH LTD  FULFORD INDIA  BIOCON LTD  

Compare SUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green, L&T Buyback, and Top Stocks in Action(Pre-Open)

On Monday, share markets in India opened on a positive note and ended the day in green after an optimistic day of trading.

Views on news

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

This Trend Will Produce a Once in a Lifetime Opportunity to Buy Stocks(The 5 Minute Wrapup)

Jan 15, 2019

Unlike his habit of pouring out stock wisdom in his annual letters to shareholders, Buffett spoke of this trend only once every few decades.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

My Next Small Cap Recommendation Is Practically a 'No Brainer'(Profit Hunter)

Jan 14, 2019

With a strong debt free balance sheet in its favour, attractive dividends and trading at almost lifetime lows, this investing idea is almost a no brainer.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 22, 2019 09:37 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - BIOCON LTD COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS